BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 4219256)

  • 1. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
    Loubatières A; Loubatières-Mariani MM
    Endocrinol Exp; 1974 Jun; 8(2):75-87. PubMed ID: 4209693
    [No Abstract]   [Full Text] [Related]  

  • 3. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 6. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
    Mariani MM
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF
    Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 9. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides.
    Samols E; Weir GC; Ramseur R; Day JA; Patel YC
    Metabolism; 1978 Sep; 27(9 Suppl 1):1219-21. PubMed ID: 682983
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A; Mariani MM; Alric R
    Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin secretion studied on isolated perfused rat pancreas. II. Effects of catecholamines and adrenergic blocking drugs].
    Loubatières A; Mariani MM; Chapal J
    Diabetologia; 1970 Dec; 6(6):533-41. PubMed ID: 4395476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synergetic action between glucose and hypotlycemic sulfamides on insulin secretion].
    Loubatières A; Mariani MM; Chapal J
    C R Acad Hebd Seances Acad Sci D; 1968 Jul; 267(1):123-6. PubMed ID: 4971521
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
    Seltzer HS; Crout JR
    Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose.
    Basabe JC; Lopez NL; Viktora JK; Wolff FW
    Diabetes; 1971 Jul; 20(7):449-56. PubMed ID: 5556282
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of thiazides upon insulin secretion in vitro.
    Malaisse W; Malaisse-Legae F
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):235-9. PubMed ID: 4868989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of increasing concentrations of glucose on insulin secretion. Synergy between glucose and hypoglycemic sulfonamides].
    Loubatières A; Mariani MM; Chapal J
    C R Seances Soc Biol Fil; 1968; 162(8):1575-80. PubMed ID: 4238184
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the stimulating action of tolbutamide on the secretion of insulin using mannoheptulose and diazoxide.
    Loubatières-Mariani MM; Loubatières AL; Chapal J
    Diabetologia; 1973 Apr; 9(2):152-7. PubMed ID: 4716116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.